blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4169908

EP4169908 - FORMULATIONS OF ENZALUTAMIDE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  23.02.2024
Database last updated on 07.10.2024
FormerThe application has been published
Status updated on  24.03.2023
Most recent event   Tooltip23.02.2024Application deemed to be withdrawnpublished on 27.03.2024  [2024/13]
Applicant(s)For all designated states
Medivation Prostate Therapeutics LLC
66 Hudson Boulevard East
New York, NY 10001-2192 / US
For all designated states
Astellas Pharma Inc.
2-5-1, Nihonbashi-Honcho
Chuo-ku
Tokyo 103-8411 / JP
[2023/31]
Former [2023/17]For all designated states
Medivation Prostate Therapeutics LLC
235 East 42nd Street
New York, NY 10017 / US
For all designated states
Astellas Pharma Inc.
2-5-1, Nihonbashi-Honcho
Chuo-ku
Tokyo 103-8411 / JP
Inventor(s)01 / LORENZ, Douglas Alan
Bend, 97701 / US
02 / KONAGURTHU, Sanjay
Bend, 97701 / US
03 / WALD, Randy J.
Bend, 97701 / US
04 / EVERETT, Jason A.
Bend, 97701 / US
05 / MATZ, Sheila
New York, 10017 / US
06 / TAKAISHI, Yuuki
Tokyo, 103-8411 / JP
07 / SAKAI, Toshiro
Tokyo, 103-8411 / JP
08 / IRIE, Ryousuke
Tokyo, 103-8411 / JP
09 / OBA, Shinsuke
Tokyo, 103-8411 / JP
10 / TOYOTA, Hiroyasu
Tokyo, 103-8411 / JP
11 / NISHIMURA, Koji
Tokyo, 103-8411 / JP
12 / KANBAYASHI, Atsushi
Tokyo, 103-8411 / JP
 [2023/17]
Representative(s)Wilson, Justin Scott
Withers & Rogers LLP
2 London Bridge
London SE1 9RA / GB
[2023/17]
Application number, filing date22197255.711.09.2013
[2023/17]
Priority number, dateUS201261699351P11.09.2012         Original published format: US 201261699351 P
[2023/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4169908
Date:26.04.2023
Language:EN
[2023/17]
Search report(s)(Supplementary) European search report - dispatched on:EP03.03.2023
ClassificationIPC:C07D233/86, A61K31/4166, A61P35/00, A61K9/14, A61K9/20, A61K9/16, A61P13/08, A61P15/00, A61P15/08, A61P15/14, A61P43/00
[2023/17]
CPC:
A61K9/1635 (EP,IL); A61K31/4164 (EA,IL,US); A61K9/2054 (EP,IL,US);
A61K31/4166 (EP,IL,US); A61K47/32 (IL,US); A61K47/38 (IL,US);
A61K9/10 (IL,US); A61K9/146 (EP); A61K9/16 (IL,US);
A61K9/1652 (EP,IL,US); A61K9/2027 (EP); A61K9/2095 (EP,IL,US);
A61P13/08 (EP,IL); A61P15/00 (EP,IL); A61P15/08 (EP,IL);
A61P15/14 (EP,IL); A61P35/00 (EP,EA,IL); A61P43/00 (EP,IL);
C07D233/86 (EP,EA,IL,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/17]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ENZALUTAMIDFORMULIERUNGEN[2023/17]
English:FORMULATIONS OF ENZALUTAMIDE[2023/17]
French:FORMULATIONS D'ENZALUTAMIDE[2023/17]
Examination procedure27.10.2023Application deemed to be withdrawn, date of legal effect  [2024/13]
17.11.2023Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2024/13]
Parent application(s)   TooltipEP13766437.1  / EP2895463
EP20177837.0  / EP3725778
EP21190086.5  / EP3971167
Divisional application(s)EP23205739.8  / EP4324527
EP24198653.8
Fees paidRenewal fee
22.09.2022Renewal fee patent year 03
22.09.2022Renewal fee patent year 04
22.09.2022Renewal fee patent year 05
22.09.2022Renewal fee patent year 06
22.09.2022Renewal fee patent year 07
22.09.2022Renewal fee patent year 08
22.09.2022Renewal fee patent year 09
22.09.2022Renewal fee patent year 10
24.08.2023Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO03063821  (PFIZER PROD INC [US], et al);
 [A]US2007004753  (SAWYERS CHARLES L [US], et al);
by applicantUS2002009494
 US2002031547
 US7709517
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.